Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Evotec Se (EVO)

Evotec Se (EVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook PR Newswire - Mon Jul 13, 2:43PM CDT

D isclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014  

EVT : 27.10 (+0.04%)
EVO : 1.9600 (-0.51%)
Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics PR Newswire - Tue Jun 30, 1:16AM CDT

SEATTLE and HAMBURG, Germany , June 30, 2026 /PRNewswire/ -- Evotec SE (NASDAQ: EVO) (Frankfurt Prime Standard: EVT) today announced the expansion of its Just – Evotec Biologics services with J.TRAIN,...

EVO : 1.9600 (-0.51%)
Evotec Reports Results of the Annual General Meeting 2026 PR Newswire - Thu Jun 11, 11:02AM CDT

11.06.2026 / 15:30 CET/CEST The issuer is solely responsible for the content of this announcement.

EVT : 27.10 (+0.04%)
EVO : 1.9600 (-0.51%)
Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025 ACCESS Newswire - Mon Apr 28, 2025

HAMBURG, DE / ACCESS Newswire / April 29, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its interim statement for the first quarter of 2025...

EVO : 1.9600 (-0.51%)
Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb ACCESS Newswire - Wed Apr 23, 2025

Key scientific achievements expand the pipeline of high value molecular glue degraders for unmet medical needs

EVO : 1.9600 (-0.51%)
Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results ACCESS Newswire - Wed Apr 16, 2025

Evotec sharpens focus on pioneering drug discovery and charts clear path toward sustainable profitable growth

EVO : 1.9600 (-0.51%)
Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025 ACCESS Newswire - Thu Apr 10, 2025

HAMBURG, DE / ACCESS Newswire / April 10, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for 2024 on Thursday, 17 April...

EVO : 1.9600 (-0.51%)
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb ACCESS Newswire - Mon Mar 3, 2025

Ongoing strategic partnership advances joint pipeline in neurodegeneration research

EVO : 1.9600 (-0.51%)
BMY : 60.74 (+0.38%)
Evotec Announces Change in Management Board ACCESS Newswire - Tue Feb 25, 2025

Laetitia Rouxel steps down as Chief Financial Officer effective 28 February 2025

EVO : 1.9600 (-0.51%)
Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases ACCESS Newswire - Tue Jan 21, 2025

Yonsei University, Zymedi and Evotec receive US$ 4.5m grant from the Korea Institute of Advanced Technology under the Korean Ministry for Trade, Industry and Energy

EVO : 1.9600 (-0.51%)

Barchart Exclusives

Multiple Compression Is a Real Threat to Microsoft Stock, But Its Core Story Isn’t Broken Barchart - 54 minutes ago
Citi cut its Microsoft price target from $620 to $570 while maintaining a 'Buy' rating, citing ongoing software multiple compression after the stock dropped 10%. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.